Mark has over 19 years of experience in the pharmaceutical industry and is currently a member of Boehringer Ingelheim’s Venture Fund focused on digital health investments. Prior to joining the Fund, Mark was the Global Head of Contracts and Alliance Management, a team within Business Development and licensing that was responsible for leading transactions and the alliance management of collaborations with academic and biotechnology partners. Mark’s career has afforded diverse roles in drug discovery, operations, CRO management, financial management, and business development.
Mark is attending / has attended:
Venture Summit Virtual Connect 3
VSVC West 2021
Venture Summit Virtual Connect 21